UNSPSC 51391728: Metiprenaline

This classification denotes a beta-adrenergic agonist with the molecular formula C12H19NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1WBF92D66N, chemically known as vanillyl alcohol, alpha-((isopropylamino)methyl)- but generally known as metiprenaline, which bears US NIH Compound Identifier 68951. European Medicines Agency schedules Metiprenaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08893MIG.

UNSPSC 51391728 Metiprenaline is a Commodity code that covers pharmaceutical products used in emergency response and harm-reduction initiatives at state and local jurisdictions. The actual procurement activity under this code reflects public health emergency needs: state and local governments are buying naloxone (an opioid antagonist) and related drug-deactivation systems to support community health and overdose-response programs. Issuing bodies soliciting under this code include county health departments and public health authorities managing substance-abuse prevention and emergency medical response.

Seminole County, Florida posted an IFB on June 30, 2026 (IFB60459723LAS) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The response deadline was July 26, 2023, with bidders required to submit unit costs, maintain workers' compensation and general liability insurance, comply with drug-free workplace and E-Verify requirements, and include all shipping and delivery costs in their proposal. The contract was structured as a two-year initial term with an optional one-year renewal and a three-month probationary termination period. The procurement indicates potential FEMA funding and includes compliance with federal environmental regulations. No other recent state and local opportunities under this code are present in the source.